{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:45:26Z","timestamp":1790711126778,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41433-020-0898-9","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T16:04:42Z","timestamp":1588781082000},"page":"1916-1924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["A 20-year audit of retinoblastoma treatment outcomes"],"prefix":"10.1038","volume":"34","author":[{"given":"Ahmet Kaan","family":"G\u00fcnd\u00fcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0161-8078","authenticated-orcid":false,"given":"Ibadulla","family":"Mirzayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6302-9175","authenticated-orcid":false,"given":"Emine","family":"Temel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurdan","family":"Ta\u00e7y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Din\u00e7aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdal Kenan","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda Seher","family":"\u00d6zalp Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-5469","authenticated-orcid":false,"given":"Mehmed U\u011fur","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"key":"898_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","volume":"93","author":"T Kivel\u00e4","year":"2009","unstructured":"Kivel\u00e4 T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129\u201331.","journal-title":"Br J Ophthalmol"},{"key":"898_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/107327480401100506","volume":"11","author":"CL Shields","year":"2004","unstructured":"Shields CL, Shields JA. Diagnosis and management of retinoblastoma. Cancer Control. 2004;11:317\u201327.","journal-title":"Cancer Control"},{"key":"898_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pbc.20606","volume":"47","author":"G Chantada","year":"2006","unstructured":"Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006;47:801\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"898_CR4","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","volume":"113","author":"CL Shields","year":"2006","unstructured":"Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276\u201380.","journal-title":"Ophthalmology"},{"key":"898_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1200\/JGO.2016.005595","volume":"3","author":"CCDS Mattosinho","year":"2016","unstructured":"Mattosinho CCDS, Grigorovski N, Lucena E, Ferman S, Soaresde Moura ATM, Portes AF. Prediagnostic intervals in retinoblastoma: experience at a noncology center in Brazil. J Glob Oncol. 2016;3:323\u201330.","journal-title":"J Glob Oncol"},{"key":"898_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/pbc.21350","volume":"49","author":"BL Gallie","year":"2007","unstructured":"Gallie BL, Zhao J, Vandezande K, White A, Chan HS. Global issues and opportunities for optimized retinoblastoma care. Pediatr Blood Cancer. 2007;49:1083\u201390.","journal-title":"Pediatr Blood Cancer"},{"key":"898_CR7","unstructured":"Shields JA, Shields CL. Retinoblastoma. In: Shields JA, Shields CL (eds). Intraocular Tumors. An Atlas and Textbook (2nd ed). Lippincott Williams Wilkins: Philadelphia, PA; 2008:293\u2013365."},{"key":"898_CR8","doi-asserted-by":"publisher","first-page":"e5204","DOI":"10.1097\/MD.0000000000005204","volume":"95","author":"J Gao","year":"2016","unstructured":"Gao J, Zeng J, Guo B, He W, Chen J, Lu F, et al. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine. 2016;95:e5204.","journal-title":"Medicine"},{"key":"898_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/pbc.22843","volume":"56","author":"GL Chantada","year":"2011","unstructured":"Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, et al. Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer. 2011;56:341\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"898_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.sjopt.2010.10.010","volume":"25","author":"MJ Ali","year":"2011","unstructured":"Ali MJ, Honavar SG, Reddy VA. Orbital retinoblastoma: present status and future challenges\u2013A review. Saudi J Ophthalmol. 2011;25:159\u201367.","journal-title":"Saudi J Ophthalmol"},{"key":"898_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1442-9071.2005.01010.x","volume":"33","author":"B Badhu","year":"2005","unstructured":"Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005;33:386\u20139.","journal-title":"Clin Exp Ophthalmol"},{"key":"898_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijrobp.2011.11.002","volume":"84","author":"N Murakami","year":"2012","unstructured":"Murakami N, Suzuki S, Ito Y, Yoshimura R, Inaba K, Kuroda Y, et al. 106 ruthenium plaque therapy (RPT) for retinoblastoma. Int J Radiat Oncol Biol Phys. 2012;84:59\u201365.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"898_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","volume":"133","author":"CL Shields","year":"2002","unstructured":"Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol. 2002;133:657\u201364.","journal-title":"Am J Ophthalmol"},{"key":"898_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.neo.2018.05.007","volume":"20","author":"JH Francis","year":"2018","unstructured":"Francis JH, Roosipu N, Levin AM, Brodie SE, Dunkel IJ, Gobin YP, et al. Current treatment of bilateral retinoblastoma: the impact of intraarterial and intravitreous chemotherapy. Neoplasia. 2018;20:757\u201363.","journal-title":"Neoplasia"},{"key":"898_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/APO.0000000000000172","volume":"5","author":"CL Shields","year":"2016","unstructured":"Shields CL, Jorge R, Say EA, Magrath G, Alset A, Caywood E, et al. Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of retinoblastoma. Asia Pac J Ophthalmol. 2016;5:97\u2013103.","journal-title":"Asia Pac J Ophthalmol"},{"key":"898_CR16","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","volume":"129","author":"CL Shields","year":"2011","unstructured":"Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129:1399\u2013406.","journal-title":"Arch Ophthalmol"},{"key":"898_CR17","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","volume":"96","author":"FL Munier","year":"2012","unstructured":"Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96:1078\u201383.","journal-title":"Br J Ophthalmol"},{"key":"898_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/bjophthalmol-2018-312037","volume":"103","author":"DH Abramson","year":"2019","unstructured":"Abramson DH, Ji X, Francis CH, Catalanotti F, Catalanotti F, Brodie SE, et al. Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds. Br J Ophthalmol. 2019;103:488\u201393.","journal-title":"Br J Ophthalmol"},{"key":"898_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1590\/S1807-59322009000500010","volume":"64","author":"MT Bonanomi","year":"2009","unstructured":"Bonanomi MT, Almeida M, Cristofani LM, Odone Filho V. Retinoblastoma: a three-year-study at a Brazilian medical school hospital. Clinics. 2009;64:427\u201334.","journal-title":"Clinics"},{"key":"898_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/bjo.2003.035642","volume":"88","author":"C Leal-Leal","year":"2004","unstructured":"Leal-Leal C, Flores-Rojo M, Medina-Sans\u00f3n A, Cerecedo-D\u00edaz F, S\u00e1nchez-F\u00e9lix S, Gonz\u00e1lez-Ramella O, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88:1074\u20137.","journal-title":"Br J Ophthalmol"},{"key":"898_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0039-6257(01)00279-X","volume":"47","author":"PT Finger","year":"2002","unstructured":"Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol. 2002;47:1\u201316.","journal-title":"Surv Ophthalmol"}],"updated-by":[{"DOI":"10.1038\/s41433-020-1119-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-0898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-0898-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-0898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:18Z","timestamp":1684617078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-0898-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["898"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-0898-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41433-020-1119-2","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-020-1119-2","URL":"https:\/\/doi.org\/10.1038\/s41433-020-1119-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}